These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 17548809)

  • 21. Determination of the optimal route of administration of Salmonella typhimurium A1-R to target breast cancer in nude mice.
    Zhang Y; Tome Y; Suetsugu A; Zhang L; Zhang N; Hoffman RM; Zhao M
    Anticancer Res; 2012 Jul; 32(7):2501-8. PubMed ID: 22753706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Future of Bacterial Therapy of Cancer.
    Hoffman RM
    Methods Mol Biol; 2016; 1409():177-84. PubMed ID: 26846811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salmonella promoters preferentially activated inside tumors.
    Arrach N; Zhao M; Porwollik S; Hoffman RM; McClelland M
    Cancer Res; 2008 Jun; 68(12):4827-32. PubMed ID: 18559530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor-targeting Salmonella typhimurium A1-R overcomes nab-paclitaxel resistance in a cervical cancer PDOX mouse model.
    Miyake K; Murata T; Murakami T; Zhao M; Kiyuna T; Kawaguchi K; Igarashi K; Miyake M; Lwin TM; Hozumi C; Komatsu S; Kikuchi T; Bouvet M; Shimoya K; Singh SR; Endo I; Hoffman RM
    Arch Gynecol Obstet; 2019 Jun; 299(6):1683-1690. PubMed ID: 30953192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-targeting Salmonella typhimurium A1-R is a highly effective general therapeutic for undifferentiated soft tissue sarcoma patient-derived orthotopic xenograft nude-mouse models.
    Igarashi K; Kawaguchi K; Kiyuna T; Miyake K; Miyake M; Singh AS; Eckardt MA; Nelson SD; Russell TA; Dry SM; Li Y; Yamamoto N; Hayashi K; Kimura H; Miwa S; Tsuchiya H; Singh SR; Eilber FC; Hoffman RM
    Biochem Biophys Res Commun; 2018 Mar; 497(4):1055-1061. PubMed ID: 29481803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-targeting Salmonella typhimurium A1-R arrests a doxorubicin-resistant PDGFRA-amplified patient-derived orthotopic xenograft mouse model of pleomorphic liposarcoma.
    Kiyuna T; Tome Y; Murakami T; Zhao M; Miyake K; Igarashi K; Kawaguchi K; Miyake M; Oshiro H; Higuchi T; Li Y; Dry SM; Nelson SD; Russell TA; Eckardt MA; Singh AS; Kanaya F; Eilber FC; Hoffman RM
    J Cell Biochem; 2018 Sep; 119(9):7827-7833. PubMed ID: 29932244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-efficacy targeting of colon-cancer liver metastasis with Salmonella typhimurium A1-R via intra-portal-vein injection in orthotopic nude-mouse models.
    Kawaguchi K; Murakami T; Suetsugu A; Kiyuna T; Igarashi K; Hiroshima Y; Zhao M; Zhang Y; Bouvet M; Clary BM; Unno M; Hoffman RM
    Oncotarget; 2017 Mar; 8(12):19065-19073. PubMed ID: 27683127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor-targeting Salmonella typhimurium A1-R combined with temozolomide regresses malignant melanoma with a BRAF-V600E mutation in a patient-derived orthotopic xenograft (PDOX) model.
    Kawaguchi K; Igarashi K; Murakami T; Chmielowski B; Kiyuna T; Zhao M; Zhang Y; Singh A; Unno M; Nelson SD; Russell TA; Dry SM; Li Y; Eilber FC; Hoffman RM
    Oncotarget; 2016 Dec; 7(52):85929-85936. PubMed ID: 27835903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salmonella typhimurium A1-R and Cell-Cycle Decoy Therapy of Cancer.
    Hoffman RM; Yano S
    Methods Mol Biol; 2016; 1409():165-75. PubMed ID: 26846810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer-cell killing by engineered Salmonella imaged by multiphoton tomography in live mice.
    Uchugonova A; Zhao M; Zhang Y; Weinigel M; K├Ânig K; Hoffman RM
    Anticancer Res; 2012 Oct; 32(10):4331-7. PubMed ID: 23060555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of spontaneous and experimental lung metastasis of soft-tissue sarcoma by tumor-targeting Salmonella typhimurium A1-R.
    Miwa S; Zhang Y; Baek KE; Uehara F; Yano S; Yamamoto M; Hiroshima Y; Matsumoto Y; Kimura H; Hayashi K; Yamamoto N; Bouvet M; Tsuchiya H; Hoffman RM; Zhao M
    Oncotarget; 2014 Dec; 5(24):12849-61. PubMed ID: 25528763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vessel destruction by tumor-targeting Salmonella typhimurium A1-R is enhanced by high tumor vascularity.
    Liu F; Zhang L; Hoffman RM; Zhao M
    Cell Cycle; 2010 Nov; 9(22):4518-24. PubMed ID: 21135579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combining Tumor-Selective Bacterial Therapy with Salmonella typhimurium A1-R and Cancer Metabolism Targeting with Oral Recombinant Methioninase Regressed an Ewing's Sarcoma in a Patient-Derived Orthotopic Xenograft Model.
    Miyake K; Kiyuna T; Li S; Han Q; Tan Y; Zhao M; Oshiro H; Kawaguchi K; Higuchi T; Zhang Z; Razmjooei S; Barangi M; Wangsiricharoen S; Murakami T; Singh AS; Li Y; Nelson SD; Eilber FC; Bouvet M; Hiroshima Y; Chishima T; Matsuyama R; Singh SR; Endo I; Hoffman RM
    Chemotherapy; 2018; 63(5):278-283. PubMed ID: 30673664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of tumor-targeting Salmonella typhimurium A1-R in combination with anti-angiogenesis therapy on a pancreatic cancer patient-derived orthotopic xenograft (PDOX) and cell line mouse models.
    Hiroshima Y; Zhang Y; Murakami T; Maawy A; Miwa S; Yamamoto M; Yano S; Sato S; Momiyama M; Mori R; Matsuyama R; Chishima T; Tanaka K; Ichikawa Y; Bouvet M; Endo I; Zhao M; Hoffman RM
    Oncotarget; 2014 Dec; 5(23):12346-57. PubMed ID: 25402324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor-targeting
    Kiyuna T; Tome Y; Uehara F; Murakami T; Zhang Y; Zhao M; Kanaya F; Hoffman RM
    Anticancer Res; 2018 Jan; 38(1):159-164. PubMed ID: 29277768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of Salmonella typhimurium A1-R versus chemotherapy on a pancreatic cancer patient-derived orthotopic xenograft (PDOX).
    Hiroshima Y; Zhao M; Maawy A; Zhang Y; Katz MH; Fleming JB; Uehara F; Miwa S; Yano S; Momiyama M; Suetsugu A; Chishima T; Tanaka K; Bouvet M; Endo I; Hoffman RM
    J Cell Biochem; 2014 Jul; 115(7):1254-61. PubMed ID: 24435915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The preclinical discovery of bacterial therapy for the treatment of metastatic cancer with unique advantages.
    Hoffman RM
    Expert Opin Drug Discov; 2012 Jan; 7(1):73-83. PubMed ID: 22468895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High efficacy of tumor-targeting Salmonella typhimurium A1-R on a doxorubicin- and dactolisib-resistant follicular dendritic-cell sarcoma in a patient-derived orthotopic xenograft PDOX nude mouse model.
    Kiyuna T; Murakami T; Tome Y; Kawaguchi K; Igarashi K; Zhang Y; Zhao M; Li Y; Bouvet M; Kanaya F; Singh A; Dry S; Eilber FC; Hoffman RM
    Oncotarget; 2016 May; 7(22):33046-54. PubMed ID: 27105519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primer dosing of S. typhimurium A1-R potentiates tumor-targeting and efficacy in immunocompetent mice.
    Tome Y; Zhang Y; Momiyama M; Maehara H; Kanaya F; Tomita K; Tsuchiya H; Bouvet M; Hoffman RM; Zhao M
    Anticancer Res; 2013 Jan; 33(1):97-102. PubMed ID: 23267132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor-targeting Salmonella typhimurium A1-R combined with recombinant methioninase and cisplatinum eradicates an osteosarcoma cisplatinum-resistant lung metastasis in a patient-derived orthotopic xenograft (PDOX) mouse model: decoy, trap and kill chemotherapy moves toward the clinic.
    Igarashi K; Kawaguchi K; Kiyuna T; Miyake K; Miyake M; Li S; Han Q; Tan Y; Zhao M; Li Y; Nelson SD; Dry SM; Singh AS; Elliott IA; Russell TA; Eckardt MA; Yamamoto N; Hayashi K; Kimura H; Miwa S; Tsuchiya H; Eilber FC; Hoffman RM
    Cell Cycle; 2018; 17(6):801-809. PubMed ID: 29374999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.